Tenax Therapeutics (TENX) Research & Development (2010 - 2026)
Tenax Therapeutics (TENX) reported Research & Development of $11.5 million for Q1 2026, up 103.04% on a YoY basis from $5.7 million in Q1 2025, and up 9.48% sequentially from $10.5 million in Q4 2025.
Tenax Therapeutics (TENX) Research & Development (2010 - 2026) Analysis & Trends
Tenax Therapeutics (TENX) has 16 years of Research & Development data on file, last reported at $11.5 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 103.04% year-over-year to $11.5 million; the trailing twelve-month figure through Mar 2026 stood at $38.5 million (up 145.15% YoY), and the FY2025 full-year result was $32.7 million, up 157.08% from the prior year.
- Research & Development advanced to $11.5 million in Q1 2026, from $10.5 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $11.5 million in Q1 2026 to a low of $197903.0 in Q2 2023.
- A 5-year average of $3.9 million and a median of $2.3 million in 2024 frame the typical range for Research & Development.
- Across the five-year window, Research & Development tumbled 94.74% in 2022 and jumped 1075.83% in 2024, its largest moves.
- Tracing TENX's Research & Development over 5 years: stood at $1.1 million in 2022, then soared by 49.76% to $1.7 million in 2023, then surged by 170.31% to $4.6 million in 2024, then soared by 129.43% to $10.5 million in 2025, then climbed by 9.48% to $11.5 million in 2026.
- Business Quant data shows TENX's Research & Development at $11.5 million in Q1 2026, $10.5 million in Q4 2025, and $10.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Tenax Therapeutics | 655.78 Mn | 655.78 Mn | - | 11.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.54 Mn |
| Dec 31, 2025 | 10.54 Mn |
| Sep 30, 2025 | 10.33 Mn |
| Jun 30, 2025 | 6.12 Mn |
| Mar 31, 2025 | 5.68 Mn |
| Dec 31, 2024 | 4.59 Mn |
| Sep 30, 2024 | 3.11 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Mar 31, 2024 | 2.68 Mn |
| Dec 31, 2023 | 1.70 Mn |
| Sep 30, 2023 | 1.07 Mn |
| Jun 30, 2023 | 197,903.00 |
| Mar 31, 2023 | 265,735.00 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 1.54 Mn |
| Jun 30, 2022 | 1.52 Mn |
| Mar 31, 2022 | 1.18 Mn |
| Dec 31, 2021 | 915,600.00 |
| Sep 30, 2021 | 1.16 Mn |
| Jun 30, 2021 | 693,222.00 |